Vascular Effects of Sirolimus-Eluting Versus Bare-Metal Stents in Diabetic Patients
Three-Dimensional Ultrasound Results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial
Pilar Jiménez-Quevedo, MD*,1,
Manel Sabaté, MD, PhD*,*,
Dominick J. Angiolillo, MD ,
Marco A. Costa, MD, PhD ,
Fernando Alfonso, MD, PhD*,
Joan Antoni Gómez-Hospital, MD, PhD ,
Rosana Hernández-Antolín, MD, PhD*,
Camino Bañuelos, MD*,
Javier Goicolea, MD, PhD ,
Francisco Fernández-Avilés, MD, PhD||,
Theodore Bass, MD*, , , ,||,
Javier Escaned, MD, PhD*,
Raul Moreno, MD*,
Cristina Fernández, MD, PhD*,
Carlos Macaya, MD, PhD* for the DIABETES Investigators
* San Carlos University Hospital, Madrid, Spain
University of Florida Cardiovascular Imaging Core Laboratories, Jacksonville, Florida
"Prínceps dEspanya" University Hospital, Barcelona, Spain
"Do Meixoeiro" University Hospital, Vigo, Spain
|| Clínico University Hospital, Valladolid, Spain

View larger version (31K):
[in a new window]
|
Figure 1 (Top panels) Histograms of neointima hyperplasia (NIH) volume in the sirolimus-eluting stent (SES) group (left) and the bare-metal stent (BMS) group (right). A non-Gaussian distribution is demonstrated in both groups (Kolmogorov-Smirnov test: p < 0.0001 for SES group; p = 0.02 for BMS group). The median test evidenced significant differences between groups. (Bottom panels) Histograms of percent volume obstruction in the SES group (left) and the BMS group (right). A non-Gaussian distribution is demonstrated in both groups (Kolmogorov-Smirnov test: p < 0.0001 for SES group; = 0.03 for BMS group). The median test evidenced significant differences between groups.
|
|

View larger version (117K):
[in a new window]
|
Figure 3 (Top) Intravascular imaging of a stent completely apposed immediately after the implantation. (Bottom) Same artery imaging at nine-month follow-up: Late acquired incomplete stent apposition is evidenced.
|
|
|